CLINICAL_TRIALS
trial_result
· 2009-07-08
Clinical Trial Update: Study Of SU011248 (Sunitinib) Given In A Continuous Daily Regimen In Patients With Advanced Renal Cell Cancer [Phase 2]
Summary
A Phase 2 study evaluating continuous daily dosing of sunitinib (SU011248) in patients with advanced renal cell carcinoma; results have been posted following co…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Carcinoma, Renal Cell Metastasis | Phase 2 | Status: COMPLETED | Results posted: 2009-07-08